CD4 and CD8 monoclonal antibody therapy in canine renal allografts.
Therapy with CD4 and CD8 monoclonal antibodies was evaluated in dogs which received double-haplotype MHC-mismatched renal allografts. Neither CD4 nor CD8 monoclonal antibodies given alone prolonged allografts survival (creatinine > or = 300 micromol/l) beyond 7 days. However, combined therapy...
المؤلفون الرئيسيون: | Watson, C, Cobbold, S, Davies, H, Rebello, P, Waldmann, H, Calne, R, Metcalfe, S |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
1994
|
مواد مشابهة
-
Immunosuppression of canine renal allograft recipients by CD4 and CD8 monoclonal antibodies.
حسب: Watson, C, وآخرون
منشور في: (1994) -
CD4 and CD8 monoclonal antibody therapy: strategies to prolong renal allograft survival in the dog.
حسب: Watson, C, وآخرون
منشور في: (1993) -
CD4 and CD8 monoclonal antibody therapy in the dog: strategies to induce tolerance to renal allografts.
حسب: Watson, C, وآخرون
منشور في: (1995) -
CD4 monoclonal antibodies in the preclinical dog renal allograft model.
حسب: Watson, C, وآخرون
منشور في: (1993) -
Production, selection, and testing of monoclonal antibodies to canine leukocytes in the dog kidney allograft model.
حسب: Davies, H, وآخرون
منشور في: (1994)